CAS 1922098-69-8

Formule : C23H19ClF2N2O3

InChI : InChI=1S/C23H19ClF2N2O3/c24-18-6-8-19(9-7-18)27-21(29)17-12-23(25,26)14-28(13-17)22(30)16-4-1-3-15(11-16)20-5-2-10-31-20/h1-11,17H,12-14H2,(H,27,29)

Code InChI : PMTPYUTZAJWGPE-UHFFFAOYSA-N

SMILES : C1C(CN(CC1(F)F)C(=O)C2=CC=CC(=C2)C3=CC=CO3)C(=O)NC4=CC=C(C=C4)Cl

CCG-222740

CAS : 1922098-69-8

CCG-222740

Formule : C₂₃H₁₉ClF₂N₂O₃

Degré de pureté : ≥98%

Masse moléculaire : 444.86

Ref: 54-BUP09831

N-(4-Chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

CAS : 1922098-69-8

Formule : C₂₃H₁₉ClF₂N₂O₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 444.8584

Ref: IN-DA01KJXC

CCG-222740

CAS : 1922098-69-8

CCG-222740 is an inhibitor of Rho/MRTF pathway

Formule : C₂₃H₁₉ClF₂N₂O₃

Degré de pureté : 98.76%

Couleur et forme : Solid

Masse moléculaire : 444.858

Ref: TM-T7764

N-(4-Chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

CAS : 1922098-69-8

Formule : C₂₃H₁₉ClF₂N₂O₃

Degré de pureté : 98%

Masse moléculaire : 444.86

Ref: 10-F547062

CCG-222740

CAS : 1922098-69-8

CCG-222740 is a small molecule inhibitor, which is derived from synthetic chemistry advancements aimed at developing targeted cancer therapies. It operates by modulating specific signaling pathways that are known to contribute to tumor growth and survival. Specifically, CCG-222740 targets the Rho GTPase family, which is involved in regulating cytoskeletal dynamics and cell proliferation.

Formule : C₂₃H₁₉ClF₂N₂O₃

Degré de pureté : Min. 95%

Masse moléculaire : 444.86 g/mol

Ref: 3D-XBD09869